Back
Neumora Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
NMRA
Sponsored
The dark truth about AI
Click here to learn more...
Sell
26
NMRA
Neumora Therapeutics
Last Price:
10.33
Seasonality Move:
43.48%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)Neumora Therapeutics Price Quote
$10.33
+0.01 (+-2.36%)
(Updated: December 14, 2024 at 5:44 AM ET)
Neumora Therapeutics Key Stats
Sell
26
Neumora Therapeutics (NMRA)
is a Sell
Day range:
$10.08 - $10.80
52-week range:
$8.33 - $21.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.33%
Volume:
859.2K
Avg. volume:
1M
1-year change:
-27.58%
Market cap:
$1.7B
Revenue:
$0
EPS:
$-1.84
How Much Does Neumora Therapeutics Make?
Data Unavailable
Is Neumora Therapeutics Growing As A Company?
Data Unavailable
Neumora Therapeutics Stock Price Performance
-
Did Neumora Therapeutics Stock Go Up Last Month?
Neumora Therapeutics share price went down by -4.22% last month -
Did NMRA's Share Price Rise Over The Last Year?
NMRA share price fell by -27.58% over the past 1 year
What Is Neumora Therapeutics 52-Week High & Low?
-
What Is Neumora Therapeutics’s 52-Week High Share Price?
Neumora Therapeutics has traded as high as $21.00 over the past 52 weeks -
What Is Neumora Therapeutics’s 52-Week Low Share Price?
Neumora Therapeutics has traded as low as $8.33 over the past 52 weeks
Neumora Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Neumora Therapeutics?
-
How Much Debt Does Neumora Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Neumora Therapeutics Have?
Cash and short term investments quarterly total is $341.3M -
What Is Neumora Therapeutics’s Book Value Per Share?
Book value per share is 2.00
Is Neumora Therapeutics Cash Flow Positive?
-
What Is NMRA Cash Flow From Operations?
Cash flow from operations (TTM) is -$184M -
What Is Neumora Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $5.5M -
What Is Neumora Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $41.9M
Neumora Therapeutics Return On Invested Capital
Data Unavailable
Neumora Therapeutics Earnings Date & Stock Price
-
What Is Neumora Therapeutics's Stock Price Today?
A single share of NMRA can be purchased today for 10.32 -
What Is Neumora Therapeutics’s Stock Symbol?
Neumora Therapeutics trades on the nasdaq under the ticker symbol: NMRA -
When Is Neumora Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Neumora Therapeutics is scheduled on March 7, 2025 -
When Is NMRA's next ex-dividend date?
Neumora Therapeutics's next ex-dividend date is December 15, 2024 -
How To Buy Neumora Therapeutics Stock?
You can buy Neumora Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Neumora Therapeutics Competitors
-
Who Are Neumora Therapeutics's Competitors?
Below is a list of companies who compete with Neumora Therapeutics or are related in some way:
Neumora Therapeutics Dividend Yield
-
What Is NMRA Dividend Yield?
Neumora Therapeutics’s dividend yield currently is 0% -
What Is Neumora Therapeutics’s Payout Ratio?
Neumora Therapeutics’s payout ratio is 0% -
When Did Neumora Therapeutics Last Pay A Dividend?
The latest dividend pay date is December 15, 2024 -
What Is Neumora Therapeutics’s Dividend Per Share?
Neumora Therapeutics pays a dividend of $0.00 per share
Neumora Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -18.33% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 23.33 |
Upside from Last Price: | 126.02% |